Revised SPC: Velphoro (sucroferric oxyhydroxide) 500 mg chewable tablets
The indication for the control of serum phosphorus levels in patients with CKD stages 4-5 or with CKD on dialysis has been extended to include use in paediatric patients aged ≥2years. SPC also updated to reflect availability of new formulation, 125 mg oral powder in sachet.
Source:
electronic Medicines compendium